4//SEC Filing
Protalix BioTherapeutics, Inc. 4
Accession 0001144204-14-050791
$PLXCIK 0001006281operating
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:30 PM ET
Size
5.0 KB
Accession
0001144204-14-050791
Insider Transaction Report
Form 4
Bronfeld Zeev
Director10% Owner
Transactions
- Sale
Common Stock
2014-08-13$2.47/sh−4,400,000$10,868,000→ 10,066,319 total(indirect: By Trust)
Footnotes (1)
- [F1]All shares of Common Stock are held by Biocell Ltd. Mr. Bronfeld disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006281
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:30 PM ET
- Size
- 5.0 KB